13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q3 2016. See the latest, Q3 2026 →

Reported value

$7.04B

−4.5% on the quarter before

Positions

44

12 new, 7 sold out

Top 10

69.3%

of the value

Est. gain

+$389.5M

on stocks held all quarter

Est. return

+7.6%

on those stocks since Q2 2016

Filed

Nov 14, 2016

On SEC EDGAR ↗

Positions as of Sep 30, 2016, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2016. Striped tiles are options.

Cheniere Energy Inc17%
Viasat Inc12%
20 others7.6%
Synchrony Finl7.0%
Allergan Plc6.6%
Antero Res Corp5.6%
Pbf Energy Inc5.1%
Dell Technologies Inc4.5%
Twenty First Centy Fox Inc4.4%
Theravance Biopharma Inc3.8%
PayPal2.9%
Twenty First Centy Fox Inc2.6%
Innoviva Inc2.3%
Veritiv Corp2.2%
Keryx Biopharmaceuticals Inc1.9%
Northstar Asset Mgmt Group I1.8%
Olin Corp1.8%
Vmware Inc1.7%
Atara Biotherapeutics Inc1.6%
Forward Pharma A/S1.6%
Liberty Interactive Corp1.4%
Colony Cap Inc1.2%
Chipmos Tech Bermuda Ltd1.1%
Northstar Rlty Fin Corp1.0%
Klx Inc1.0%

Largest buys

Since Q2 2016, sized at quarter-end prices.

  1. Synchrony Finl~$491.8MNew, 0.0% → 7.0% of the portfolio+17,565,000 shares
  2. Dell Technologies Inc~$318.0MNew, 0.0% → 4.5% of the portfolio+6,652,459 shares
  3. Northstar Asset Mgmt Group I~$128.2MNew, 0.0% → 1.8% of the portfolio+9,913,654 shares
  4. Twenty First Centy Fox Inc~$122.3MAdded, 2.8% → 4.4% of the portfolio+5,049,547 shares
  5. Pbf Energy Inc~$115.1MAdded, 3.4% → 5.1% of the portfolio+5,083,000 shares
  6. Colony Cap Inc~$81.0MNew, 0.0% → 1.2% of the portfolio+4,445,936 shares
  7. Northstar Rlty Fin Corp~$72.4MNew, 0.0% → 1.0% of the portfolio+5,498,261 shares
  8. Office Depot Inc~$46.4MNew, 0.0% → 0.7% of the portfolio+13,000,000 shares
  9. Conyers Pk Acquisition~$37.1MNew, 0.0% → 0.5% of the portfolio+3,712,500 shares
  10. Saban Cap Acquisition Corp~$23.5MNew, 0.0% → 0.3% of the portfolio+2,326,500 shares

Largest sells

Since Q2 2016, sized at quarter-end prices.

  1. E M C Corp Mass~$1.55BSold out, 21.0% → 0.0% of the portfolio−56,961,725 shares
  2. Citigroup Inc~$219.0MSold out, 3.0% → 0.0% of the portfolio−5,167,000 shares
  3. Olin Corp~$93.5MCut, 3.6% → 1.8% of the portfolio−4,557,900 shares
  4. Cheniere Energy Inc~$87.1MCut, 15.2% → 17.3% of the portfolio−1,998,217 shares
  5. Avis Budget Group~$57.6MSold out, 0.8% → 0.0% of the portfolio−1,787,227 shares
  6. Sunedison Semiconductor Ltd~$49.7MSold out, 0.7% → 0.0% of the portfolio−8,372,979 shares
  7. Vmware Inc~$47.6MCut, 1.7% → 1.7% of the portfolio−648,805 shares
  8. Innoviva Inc~$29.4MCut, 2.5% → 2.3% of the portfolio−2,678,608 shares
  9. PayPal~$27.2MCut, 2.8% → 2.9% of the portfolio−664,087 shares
  10. Och Ziff Cap Mgmt Group~$12.8MSold out, 0.2% → 0.0% of the portfolio−3,373,891 shares

Holdings

As of Sep 30, 2016; changes in shares since Jun 30, 2016.

Positions, sorted by share of the portfolio
HoldingValue
Cheniere Energy IncCOM NEW · shares −6.7% · price +16.1%17.3%$1.21B+$168.5M
Viasat IncCOM · shares 0% · price +4.6%12.2%$860.9M+$37.5M
Synchrony FinlCOM · shares New7.0%$491.8M—
Allergan PlcSHS · shares 0% · price −0.3%6.6%$461.1M−$1.6M
Antero Res CorpCOM · shares 0% · price +3.7%5.6%$390.9M+$14.1M
Pbf Energy IncCL A · shares +48% · price −4.8%5.1%$356.0M−$12.1M
Dell Technologies IncCOM CL V · shares New4.5%$318.0M—
Twenty First Centy Fox IncCL A · shares +66% · price −10.5%4.4%$308.7M−$21.8M
Theravance Biopharma IncCOM · shares 0% · price +59.7%3.8%$266.4M+$99.6M
PayPalCOM · shares −12% · price +12.2%2.9%$204.8M+$22.3M
Twenty First Centy Fox IncCL B · shares 0% · price −9.2%2.6%$180.1M−$18.3M
Innoviva IncCOM · shares −15% · price +4.4%2.3%$164.1M+$6.9M
Veritiv CorpCOM · shares 0% · price +33.5%2.2%$152.7M+$38.3M
Keryx Biopharmaceuticals IncCOM · shares 0% · price −19.8%1.9%$137.0M−$33.8M
Northstar Asset Mgmt Group ICOM · shares New1.8%$128.2M—
Olin CorpCOM PAR $1 · shares −42% · price −17.4%1.8%$126.8M−$26.7M
Vmware IncCL A COM · shares −29% · price +28.2%1.7%$117.6M+$25.9M
Atara Biotherapeutics IncCOM · shares 0% · price −5.0%1.6%$114.6M−$6.0M
Forward Pharma A/SSPONSORED ADR · shares 0% · price +15.5%1.6%$112.7M+$15.1M
Liberty Interactive CorpLBT VENT COM A · shares 0% · price +7.6%1.4%$98.5M+$6.9M
Colony Cap IncCL A · shares New1.2%$81.0M—
Chipmos Tech Bermuda LtdSHS · shares 0% · price +9.3%1.1%$74.3M+$6.3M
Northstar Rlty Fin CorpCOM · shares New1.0%$72.4M—
Klx IncCOM · shares 0% · price +13.5%1.0%$70.4M+$8.4M
Silver Run Acquisition CorpCL A · shares 0% · price +60.7%0.84%$59.1M+$22.3M
Total 44 positions100%$7.04B+$389.5M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2016 to Q3 2016: 31 stocks held throughout, up $389.5M (+7.6%).

  1. Cheniere Energy Inc+$168.5M+16%
  2. Theravance Biopharma Inc+$99.6M+60%
  3. Veritiv Corp+$38.3M+34%
  4. Viasat Inc+$37.5M+5%
  5. Vmware Inc+$25.9M+28%
  6. Pbf Energy Inc−$12.1M−5%
  7. Twenty First Centy Fox Inc−$18.3M−9%
  8. Twenty First Centy Fox Inc−$21.8M−10%
  9. Olin Corp−$26.7M−17%
  10. Keryx Biopharmaceuticals Inc−$33.8M−20%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free